Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation

Human Pathology

Volumn 28, Issue 2, 1997, Pages 183-188

  Hazelbag, Hans Marten ^a   Van Den Broek, Lambert J C M ^a   Fleuren, Gert Jan ^a   Taminiau, Antonie H M ^a   Hogendoorn, Pancras C W ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

adamantinoma of long bones; bone neoplasm; extracellular matrix; laminin, type IV collagen; osteofibrous dysplasia

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; KERATIN; LAMININ; TENASCIN;

AMELOBLASTOMA; ARTICLE; BASEMENT MEMBRANE; CELL INTERACTION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; EXTRACELLULAR MATRIX; FIBROUS DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG BONE; MESENCHYME;

EID: 0031014934     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90104-0     Document Type: Article

References (32)

1. Weiss SW, Dorfman HD: Adamantinoma of long bone: An analysis of nine new cases with emphasis on metastasizing lesions and fibrous dysplasia-like changes. HUM PATHOL 8:141-153, 1977
2. Czerniak B, Rojas-Corona RR, Dorfman HD: Morphologic diversity of long bone adamantinoma: The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer 64:2319-2334, 1989
3. Mirra JM: Adamantinoma and osteofibrous dysplasia, in Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Philadelphia, London, Lea & Febiger, 1989, pp 1204-1231
4. Hicks JD: Synovial sarcoma of the tibia. J Pathol 67:151-151, 1954
5. Lederer H, Sinclair AJ: Malignant synovioma simulating "adamantinoma of the tibia." J Pathol 67:163-168, 1954
6. Changus GW, SpeedJS, Stewart FW: Malignant angioblastoma of bone: A reappraisal of adamantinoma of long bone. Cancer 10:540-559, 1957
7. Huvos AG, Marcove RC: Adamantinoma of long bones: A clinicopathologic study of fourteen cases with vascular origin suggested. J Bone Joint Surg [Am] 57:148-154, 1975
8. Hazelbag HM, Taminiau AHM, Fleuren GJ, et al: Adamantinoma of long bones: A clinicopathological study of thirty-two cases with emphasis on histological subtype, precursor lesion and biological behavior. J Bone Joint Surg [Am] 76A:1482-1499, 1994
9. Springfield DS, Rosenberg AE, Mankin HJ, et al: Relationship between osteofibrous dysplasia and adamantinoma. Clin Orthop 309:234-244, 1994
10. Ekblom P: Developmentally regulated conversion of mesenchyme to epithelium. FASEB J 3:2141-2150, 1989
11. Hay ED: Extracellular matrix, cell skeletons, and embryonic development. Am J Med Genet 34:14-29, 1989
12. Bruijn JA, Hogendoorn PCW, Hoedemaeker PJ, et al: The extracellular matrix in pathology - a review. J Lab Clin Med 111:140-149, 1988
13. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, et al: Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139, 1986
14. Guarino M: Epithelial-to-mesenchymal change of differentiation: From embryogenetic mechanism to pathological patterns. Invited review. Histol Histopathol 10:171-184, 1995
15. Liotta LA: Tumor invasion and metastasis: Role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46:1-7, 1986
16. Guarino M, Squillaci S, Reale D, et al: The basement membranes in sarcomatoid carcinomas: An immunohistochemical study. Tumori 79:128-132, 1993
17. Guarino M, Christensen L: Immunohistochemical analysis of extracellular matrix components in synovial sarcoma. J Pathol 172:279-286, 1994
18. Hazelbag HM, Fleuren GJ, Cornelisse CJ, et al: DNA aberrations in the epithelial cell component of adamantinoma of long bones. Am J Pathol 147:1770-1779, 1995
19. Mounier F, Foidart JM, Gubler MC: Distribution of extracellular matrix glycoproteins during normal development of human kidney: An immunohistochemical study. Lab Invest 54:394-401, 1986
20. Miettinen M, Rapola J: Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Am J Surg Pathol 13:120-132, 1989
21. Sell S, Pierce GB: Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 70:6-22, 1994 (review)
22. Knapp AC, Franke WW: Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation. Cell 59:67-79, 1989
23. Pankov R, Umezawa A, Maki R, et al: Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc Natl Acad Sci USA 91:873-877, 1994
24. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 4:162-173, 1995
25. Sweet DE, Vinh TN, Devaney K: Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma: A clinicopathologic study of 30 cases. Am J Surg Pathol 16:282-290, 1992
26. Ishida T, Iijima T, Kikuchi F, et al: A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 21:493-502, 1992
27. Park YK, Unni KK, McLeod RA, et al: Osteofibrous dysplasia: Clinicopathologic study of 80 cases. HUM PATHOL 21:1339-1347, 1993
28. Bridge JA, Dembinski A, DeBoer J, et al: Clonal chromosomal abnormalities in osteofibrous dysplasia: Implications for histopathogenesis and its relationship with adamantinoma. Cancer 73:1746-1752, 1994
29. Campanacci M, Laus M: Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg [Am] 63A:367-375, 1981
30. Candeliere GA, Glorieux FH, Prud'homme J, et al: Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 332:1546-1551, 1995
31. Alman BA, Diaz-Cano SJ, Greel DA, et al: Activating Gs mutations in monostotic fibrous lesions of bone. Lab Invest 74:4A, 1996 (abstr)
32. Fechner RE, Mills SE: Fibrous dysplasia, in Rosai J, Sobin LH (eds): Atlas of Tumor Pathology: Tumors of the Bones and Joints (ed 3). Washington, DC: Armed Forces Institute of Pathology, 1992, pp 147-151